418 related articles for article (PubMed ID: 26874598)
1. Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
Yang CF; Kumar A; Gulack BC; Mulvihill MS; Hartwig MG; Wang X; D'Amico TA; Berry MF
J Thorac Cardiovasc Surg; 2016 May; 151(5):1380-8. PubMed ID: 26874598
[TBL] [Abstract][Full Text] [Related]
2. The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer.
Thomas DC; Arnold BN; Rosen JE; Salazar MC; Detterbeck FC; Blasberg JD; Boffa DJ; Kim AW
World J Surg; 2018 Jan; 42(1):161-171. PubMed ID: 28799084
[TBL] [Abstract][Full Text] [Related]
3. Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
Yang CF; Adil SM; Anderson KL; Meyerhoff RR; Turley RS; Hartwig MG; Harpole DH; Tong BC; Onaitis MW; D'Amico TA; Berry MF
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1607-13. PubMed ID: 26719403
[TBL] [Abstract][Full Text] [Related]
4. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
[TBL] [Abstract][Full Text] [Related]
5. Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
Razi SS; Nguyen D; Villamizar N
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2469-2483.e4. PubMed ID: 31928821
[TBL] [Abstract][Full Text] [Related]
6. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer.
Johnson KK; Rosen JE; Salazar MC; Boffa DJ
Ann Thorac Surg; 2016 Oct; 102(4):1166-71. PubMed ID: 27344278
[TBL] [Abstract][Full Text] [Related]
8. Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.
Ghaly G; Rahouma M; Kamel MK; Nasar A; Harrison S; Nguyen AB; Port J; Stiles BM; Altorki NK; Lee PC
Ann Thorac Surg; 2017 Oct; 104(4):1153-1158. PubMed ID: 28551047
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer.
Zhong C; Yao F; Zhao H
Ann Thorac Surg; 2013 Mar; 95(3):987-92. PubMed ID: 23261117
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer.
Kawasaki K; Sato Y; Suzuki Y; Saito H; Nomura Y; Yoshida Y
Ann Thorac Cardiovasc Surg; 2015; 21(3):217-22. PubMed ID: 25641029
[TBL] [Abstract][Full Text] [Related]
12. Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy.
Lee PC; Kamel M; Nasar A; Ghaly G; Port JL; Paul S; Stiles BM; Andrews WG; Altorki NK
Ann Thorac Surg; 2016 Mar; 101(3):1116-22. PubMed ID: 26654728
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.
Yang CF; Meyerhoff RR; Mayne NR; Singhapricha T; Toomey CB; Speicher PJ; Hartwig MG; Tong BC; Onaitis MW; Harpole DH; D'Amico TA; Berry MF
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1615-23. PubMed ID: 26719408
[TBL] [Abstract][Full Text] [Related]
14. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS; Minnich DJ
Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with non-small cell lung cancer according to lymph node disease: single pN1 vs multiple pN1 vs single unsuspected pN2.
Macia I; Ramos R; Moya J; Rivas F; Ureña A; Banque M; Escobar I; Rosado G; Rodriguez-Taboada P
Ann Surg Oncol; 2013 Jul; 20(7):2413-8. PubMed ID: 23378017
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer.
Shin S; Kim HK; Choi YS; Kim K; Kim J; Shim YM
Ann Thorac Surg; 2013 Sep; 96(3):969-75; discussion 975-6. PubMed ID: 23916803
[TBL] [Abstract][Full Text] [Related]
17. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
18. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
Wang S; Zhou W; Zhang H; Zhao M; Chen X
Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer.
Sakuraba M; Takahashi N; Oh S; Miyasaka Y; Inagaki T; Suzuki K
Ann Thorac Cardiovasc Surg; 2011; 17(2):124-9. PubMed ID: 21597408
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
